The development of an adequate technic for determining plasma quinacrine concentrations1 has facilitated the investigation of several important phases of therapy for soldiers evacuated from the South Pacific with chronic relapsing Plasmodium vivax malaria. The concentrations of quinacrine in plasma attained at selected intervals as the result of oral administration of known amounts of the drug have been determined for specific dosages. Determinations were made on 6,733 specimens from 291 patients during and after treatment for four hundred and twelve attacks of malaria at Harmon General Hospital.
The method of Brodie and Udenfriend1 was employed in the determination of the concentration of quinacrine in plasma. Plasma was used instead of whole blood because these investigators stated that variations in values in whole blood quinacrine concentrations are often reflections of changes in the number of leukocytes, since they contain a concentration several hundred times that of plasma. Shortly
Thank you for submitting a comment on this article. It will be reviewed by JAMA Internal Medicine editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 8
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.